Nosocomial outbreaks of multiresistant bacteria: extended-spectrum beta-lactamases have arrived in North America
- PMID: 8338300
- DOI: 10.7326/0003-4819-119-5-199309010-00015
Nosocomial outbreaks of multiresistant bacteria: extended-spectrum beta-lactamases have arrived in North America
Comment on
-
Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins.Ann Intern Med. 1993 Sep 1;119(5):353-8. doi: 10.7326/0003-4819-119-5-199309010-00001. Ann Intern Med. 1993. PMID: 8135915
Similar articles
-
Multiresistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae causing an outbreak of nosocomial bloodstream infection.Infect Control Hosp Epidemiol. 2001 Nov;22(11):723-5. doi: 10.1086/501854. Infect Control Hosp Epidemiol. 2001. PMID: 11842996
-
Outbreak of nosocomial sepsis and pneumonia in a newborn intensive care unit by multiresistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: high impact on mortality.Infect Control Hosp Epidemiol. 2001 Nov;22(11):725-8. doi: 10.1086/501855. Infect Control Hosp Epidemiol. 2001. PMID: 11842997
-
Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.Infection. 2007 Oct;35(5):339-45. doi: 10.1007/s15010-007-6356-9. Epub 2007 Aug 25. Infection. 2007. PMID: 17721736
-
The incidence of beta-lactamase-producing pathogens.APMIS Suppl. 1989;5:2-8. APMIS Suppl. 1989. PMID: 2660867 Review.
-
Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).Acta Microbiol Immunol Hung. 1997;44(4):309-25. Acta Microbiol Immunol Hung. 1997. PMID: 9554165 Review.
Cited by
-
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.Antimicrob Agents Chemother. 1997 May;41(5):1053-7. doi: 10.1128/AAC.41.5.1053. Antimicrob Agents Chemother. 1997. PMID: 9145868 Free PMC article.
-
Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae.Antimicrob Resist Infect Control. 2015 May 1;4:14. doi: 10.1186/s13756-015-0055-6. eCollection 2015. Antimicrob Resist Infect Control. 2015. PMID: 25932324 Free PMC article.
-
Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.Antimicrob Agents Chemother. 2016 Jul 22;60(8):4638-45. doi: 10.1128/AAC.00383-16. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27185805 Free PMC article.
-
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1995 Apr;49(4):577-617. doi: 10.2165/00003495-199549040-00008. Drugs. 1995. PMID: 7789291 Review.
-
Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.Clin Microbiol Rev. 1998 Oct;11(4):589-603. doi: 10.1128/CMR.11.4.589. Clin Microbiol Rev. 1998. PMID: 9767057 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources